1.15
0.88%
+0.01
Handel nachbörslich:
1.15
Akebia Therapeutics Inc. Aktie (AKBA) Neueste Nachrichten
Analyzing Atea Pharmaceuticals (NASDAQ:AVIR) & Akebia Therapeutics (NASDAQ:AKBA) - Defense World
Defense World
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Short Interest Down 13.4% in April - Defense World
Defense World
Will Akebia Therapeutics (AKBA) Report Negative Earnings Next Week? What You Should Know - Yahoo New Zealand News
Yahoo New Zealand News
Akebia Therapeutics executive sells $15,140 in company stock By Investing.com - Investing.com Canada
Investing.com Canada
Akebia Therapeutics COO Michel Dahan sells $43.9k in stock - Investing.com Australia
Investing.com Australia
Akebia Therapeutics executive sells $15,140 in company stock By Investing.com - Investing.com
Investing.com
Akebia Therapeutics COO Michel Dahan sells $43.9k in stock - Investing.com India
Investing.com India
Akebia Therapeutics COO Michel Dahan sells $43.9k in stock - Investing.com South Africa
Investing.com South Africa
Akebia Therapeutics COO Michel Dahan sells $43.9k in stock - Investing.com Canada
Investing.com Canada
Akebia Therapeutics COO Michel Dahan sells $43.9k in stock - Investing.com
Investing.com
Akebia Therapeutics executive sells $15,140 in company stock By Investing.com - Investing.com UK
Investing.com UK
Akebia Therapeutics COO Michel Dahan sells $43.9k in stock By Investing.com - Investing.com UK
Investing.com UK
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Short Interest Update - MarketBeat
MarketBeat
Akebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor Conference - Citizentribune
Citizentribune
Akebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor Conference - Investing.com India
Investing.com India
Akebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor Conference - PR Newswire
PR Newswire
Akebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor Conference - Investing.com South Africa
Investing.com South Africa
Should You Worry About Akebia Therapeutics, Inc.'s (NASDAQ:AKBA) CEO Pay Cheque? - Yahoo News UK
Yahoo News UK
Do Options Traders Know Something About Akebia (AKBA) Stock We Don't? - Yahoo News Australia
Yahoo News Australia
Should You Worry About Akebia Therapeutics, Inc.'s (NASDAQ:AKBA) CEO Pay Cheque? - Yahoo News UK
Yahoo News UK
Revenue Downgrade: Here's What Analysts Forecast For Akebia Therapeutics, Inc. (NASDAQ:AKBA) - Yahoo Finance
Yahoo Finance
Akebia Therapeutics (NASDAQ:AKBA) Issues Earnings Results - MarketBeat
MarketBeat
Akebia Therapeutics Reports Q1 2024 Financial Results: A Detailed Overview - Yahoo Finance
Yahoo Finance
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2024 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
Akebia Therapeutics First Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Yahoo Finance
Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - The Malaysian Reserve
The Malaysian Reserve
Akebia Therapeutics Reports Q1 2024 Financial Results: A Detailed Overview - Yahoo Finance
Yahoo Finance
Akebia Therapeutics executive sells shares worth over $31,000 By Investing.com - Investing.com Australia
Investing.com Australia
Akebia Therapeutics executive sells shares worth over $31,000 - Investing.com ZA - Investing.com South Africa
Investing.com South Africa
Akebia Therapeutics executive sells shares worth over $31,000 By Investing.com - Investing.com
Investing.com
Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - citybiz
citybiz
Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - Citizentribune
Citizentribune
Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - Investing.com India
Investing.com India
Akebia Therapeutics (AKBA) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Canada Finance
Yahoo Canada Finance
Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - PR Newswire
PR Newswire
Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - Citizentribune
Citizentribune
Akebia Therapeutics (AKBA) Scheduled to Post Earnings on Thursday - Defense World
Defense World
Are Options Traders Betting on a Big Move in Akebia (AKBA) Stock? - Yahoo Canada Shine On
Yahoo Canada Shine On
Implied Volatility Surging for Akebia Therapeutics (AKBA) Stock Options - Yahoo Singapore News
Yahoo Singapore News
Akebia Therapeutics (AKBA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Movies Canada
Yahoo Movies Canada
Akebia Therapeutics (AKBA) Scheduled to Post Earnings on Thursday - MarketBeat
MarketBeat
Akebia Therapeutics to Report First Quarter 2024 Financial Results and Discuss Recent Business Highlights - Yahoo Finance
Yahoo Finance
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PR Newswire
PR Newswire
Akebia Therapeutics (NASDAQ:AKBA) Lowered to “Hold” at StockNews.com - Defense World
Defense World
When Can We Expect A Profit From Akebia Therapeutics, Inc. (NASDAQ:AKBA)? - Yahoo Finance
Yahoo Finance
Buy Vafseo's Approval: A New Chapter For Akebia Therapeutics In Anemia Management (AKBA) - Seeking Alpha
Seeking Alpha
Akebia Therapeutics (NASDAQ:AKBA) Upgraded by StockNews.com to "Buy" - MarketBeat
MarketBeat
Akebia's Vafseo Faces Grim Market Outlook (Rating Downgrade) (NASDAQ:AKBA) - Seeking Alpha
Seeking Alpha
Akebia Recovers From Rejection to Win FDA Approval for Anemia Drug - MedCity News
MedCity News
Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Benzinga
Kapitalisierung:
|
Volumen (24h):